ACRS
NASDAQ · Pharmaceuticals
Aclaris Therapeutics Inc
$3.90
+0.29 (+8.03%)
Performance
1D
-8.02%
1W
+4.28%
1M
+8.33%
3M
-33.22%
6M
-18.75%
1Y
+83.10%
YTD
+35.42%
Open$3.62
Previous Close$3.61
Day High$3.98
Day Low$3.61
52W High$6.60
52W Low$2.10
Volume—
Avg Volume2.70M
Market Cap591.27M
P/E Ratio—
EPS$-0.59
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$4.59
Below
SMA 200
$4.53
Below
RSI (14)
66.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
+356.2% upside
Current
$3.90
$3.90
Target
$17.79
$17.79
$13.99
$17.79 avg
$22.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.69M | 15.12M | 98.24M |
| Net Income | -80,306,092 | -112,807,059 | 16.97M |
| Profit Margin | -829.6% | -788.1% | 17.3% |
| EBITDA | -93,905,216 | -139,238,263 | 25.23M |
| Free Cash Flow | — | — | 16.84M |
| Rev Growth | -35.9% | -35.9% | +7.1% |
| Debt/Equity | — | — | 1.07 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,411.95 | +4.28% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $282.11 | +2.13% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $148.76 | +1.38% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.23 | -0.54% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | +0.00% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $82.32 | +3.68% | 12.8 | 33.59B |